M U Shad, S H Preskorn. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » Antipsychotic Agents/administration & dosageAntipsychotic Agents/adverse effectsAntipsychotic Agents/pharmacokineticsBrain/drug effectsDrug InteractionsDrug Therapy, CombinationHumansLithium Carbonate/administration & dosageLithium Carbonate/adverse effectsLithium Carbonate/pharmacokineticsNeuroleptic Malignant Syndrome/bloodNeuroleptic Malignant Syndrome/diagnosisParoxetine/administration & dosageParoxetine/adverse effectsParoxetine/pharmacokineticsPerphenazine/administration & dosagePerphenazine/adverse effectsPerphenazine/pharmacokineticsSerotonin Uptake Inhibitors/administration & dosageSerotonin Uptake Inhibitors/adverse effectsSerotonin Uptake Inhibitors/pharmacokineticsTrazodone/administration & dosageTrazodone/adverse effectsTrazodone/pharmacokinetics
Substances： See more » Antipsychotic AgentsSerotonin Uptake InhibitorsLithium CarbonateParoxetinePerphenazineTrazodone
Year: 1998 PMID： 9690705 DOI： 10.1097/00004714-199808000-00020
Source DB: PubMed Journal: J Clin Psychopharmacol ISSN： 0271-0749 Impact factor: 3.153